# Patient Reported Outcomes in Pulmonary Arterial Hypertension

> **NCT01792622** · — · WITHDRAWN · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.**

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **OTHER:** Interview
- **OTHER:** Questionnaire

## Key facts

- **NCT ID:** NCT01792622
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2021-01-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01792622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01792622, "Patient Reported Outcomes in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01792622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*